Halozyme Therapeutics Inc (HALO.OQ)
HALO.OQ on NASDAQ Stock Exchange Global Select Market
7.11USD
11:43am EDT
7.11USD
11:43am EDT
Price Change (% chg)
$-1.40 (-16.45%)
$-1.40 (-16.45%)
Prev Close
$8.51
$8.51
Open
$7.13
$7.13
Day's High
$7.38
$7.38
Day's Low
$7.00
$7.00
Volume
566,080
566,080
Avg. Vol
359,862
359,862
52-wk High
$9.10
$9.10
52-wk Low
$3.86
$3.86
About
Halozyme Therapeutics, Inc. is a biopharmaceutical company. The Company’s research focuses primarily on human enzymes that alter the extracellular matrix. The Company’s pipeline consists of multiple clinical stage products in diabetes, oncology and dermatology. The product candidates in its pipeline are based on rHuPH20, a... (more)
Overall
| Beta: | 1.63 |
| Market Cap (Mil.): | $962.68 |
| Shares Outstanding (Mil.): | 113.12 |
| Dividend: | -- |
| Yield (%): | -- |
Financials
| HALO.OQ | Industry | Sector | |
|---|---|---|---|
| P/E (TTM): | -- | 14.86 | 16.01 |
| EPS (TTM): | -0.51 | -- | -- |
| ROI: | -53.66 | 7.49 | 15.63 |
| ROE: | -102.40 | 12.26 | 19.20 |
UPDATE 1-Halozyme drug delivery technology in doubt after trial halted
* Says partner ViroPharma halts trial after unexpected antibody production
BRIEF-Halozyme Therapeutics shares up 27 pct in heavy volume
NEW YORK, March 22 - Halozyme Therapeutics Inc : * Shares extend advance in heavy volume, up 27 percent
Competitors
| Price | Change | |
|---|---|---|
| Novo Nordisk A/S (NOVOb.CO) | kr.975.00 | +27.00 |
| Sanofi SA (SASY.PA) | €76.85 | -3.32 |
| Eli Lilly & Co. (LLY.N) | $53.30 | +0.19 |
| MannKind Corporation (MNKD.OQ) | $8.12 | +0.40 |
| Biodel Inc (BIOD.OQ) | $4.97 | +0.06 |
Earnings vs.
Estimates
Analyst Research Reports
| Report Title | Price |
|---|---|
|
Provider: ValuEngine, Inc.
|
$25.00
|
|
Provider: Thomson Reuters Stock Report
|
$25.00
|
|
Provider: S&P Capital IQ Quantitative Report
|
$69.00
|
|
Provider: Pechala's Reports
|
$15.00
|
|
Provider: Reuters Investment Profile
|
$20.00
|
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

